## **Core Concept**
Multiple myeloma is a type of hematological malignancy characterized by the proliferation of a specific type of cell in the bone marrow. This condition leads to an overproduction of a single type of immunoglobulin or its components. The disease is a plasma cell dyscrasia.

## **Why the Correct Answer is Right**
The correct answer, **plasma cells**, is right because multiple myeloma is indeed a cancer of plasma cells, which are a type of white blood cell present in the bone marrow. Plasma cells are crucial for producing antibodies (immunoglobulins) that help fight infections. In multiple myeloma, a clone of malignant plasma cells proliferates uncontrollably, leading to an excessive production of a single type of immunoglobulin or its components, which can cause various complications.

## **Why Each Wrong Option is Incorrect**
- **Option A:** T cells are a type of lymphocyte that plays a central role in cell-mediated immunity. While T cells are important in the immune response, their proliferation is not characteristic of multiple myeloma.
- **Option B:** B cells (B lymphocytes) are another type of white blood cell that matures into plasma cells to produce antibodies. Although B cells are precursors to plasma cells, the proliferation in multiple myeloma is specifically of the plasma cell type, not the B cell stage.
- **Option D:** Neutrophils are a type of granulocyte and are part of the innate immune system, primarily involved in combating infections. Their proliferation is not associated with multiple myeloma.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl in multiple myeloma is the presence of **CRAB** features, which are commonly used to diagnose and monitor the disease: **C**alcium elevation, **R**enal failure, **A**normia (anemia), and **B**ony lesions (lytic lesions on radiographs). These features are complications arising from the proliferation of malignant plasma cells.

## **Correct Answer:** . plasma cells